Cancer BiologybioRxivPreprint
Antibody Blockade of Ly49/MHC-I interactions enhances Innate and Adaptive Immunity Against Cancer Metastasis
Abir Kumar Panda, Surajit Sinha, Kannan Natarajan…·Ethan M. Shevach
This study shows that the anti-MHC-I antibody M1/42 enhances anti-tumor immunity by activating NK and adaptive immune cells, reducing metastasis in mouse models of cancer.
1 citation